We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CVS Caremark Corporation (NYSE: CVS) announced that it successfully completed the subsequent offering period of its tender offer for all of the outstanding common stock of Longs...
CVS Caremark Corporation (NYSE: CVS) today announced that its tender offer for shares of common stock of Longs Drug Stores Corporation (NYSE: LDG) at a price of $71.50 per share...
CVS Caremark Corporation (NYSE: CVS) announced today that it has extended the expiration for its tender offer to purchase all of the outstanding common stock of Longs Drug...
CVS Caremark Corporation (NYSE: CVS) announced today that it has extended the expiration for its tender offer to purchase all of the outstanding common stock of Longs Drug Stores Corporation...
CVS Caremark Corporation (NYSE:CVS) today reminded?stockholders of?Longs Drug Stores Corporation (NYSE:LDG)?to tender their shares into?the previously announced tender offer of...
NEW YORK, Oct. 13 /PRNewswire/ -- S&P U.S. REIT Composite constituent Post Properties Inc. (NYSE:PPS) will replace Longs Drug Stores Corp. (NYSE:LDG) in the S&P SmallCap 600 after the close of...
WALNUT CREEK, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE:LDG) today reported preliminary total retail drug store sales for the 5-week, 9-week and 35-week...
WALNUT CREEK, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE:LDG) announced today that it will open a new Longs Drugs store in Sanger, California. At Noon on...
CVS Caremark Corporation (NYSE:CVS) today took strong exception with a memorandum recently submitted to the Board of Directors of Longs Drug Stores Corporation (NYSE:LDG) by a...
DALLAS, Sept. 30 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions